Tags: US | Earns | Amgen

Amgen Profit Rises 5%, Beats Wall Street Views

Tuesday, 24 Apr 2012 04:44 PM

Biotech giant Amgen Inc. says first-quarter profit rose 5 percent on higher sales of its top two drugs and two new ones, and it easily beat Wall Street forecasts.

The maker of biologic drugs such as Enbrel for rheumatoid arthritis says net income was $1.18 billion, or $1.48 per share, up from $1.13 billion, or $1.20 per share, a year ago.

Excluding one-time items, the Thousand Oaks, Calif., company says it would have earned $1.29 billion, or $1.61 per share.

Revenue totaled $4.05 billion, up 9 percent, despite sharply lower sales for two drugs with recent safety warnings.

Analysts were expecting earnings per share of $1.46, excluding one-time items, and sales of $3.93 billion.

Amgen repeated its 2012 adjusted profit forecast of $5.90 to $6.15 per share.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
127
2012-44-24
Tuesday, 24 Apr 2012 04:44 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved